Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Reilly

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|February 14, 2002
Chronic neutrophilic leukaemia: a distinct clinical entity?John T Reilly
European Journal of Haematology. Supplementum|August 31, 2007
Practical approach to treating essential thrombocythaemia: case studiesJohn T Reilly
Hematological Oncology|February 16, 2006
Idiopathic myelofibrosis: pathogenesis to treatmentJohn T Reilly
Seminars in Oncology|October 6, 2005
Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasiaJohn T Reilly
British Journal of Haematology|March 12, 2002
Class III receptor tyrosine kinases: role in leukaemogenesisJohn T Reilly
American Journal of Hematology|December 24, 2009
Prognosis and survivorship in primary myelofibrosisJohn T Reilly
British Journal of Haematology|December 21, 2004
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?John T Reilly
Blood Reviews|October 15, 2003
Receptor tyrosine kinases in normal and malignant haematopoiesisJohn T Reilly
Acta Haematologica|October 10, 2002
Cytogenetic and molecular genetic aspects of idiopathic myelofibrosisJohn T Reilly
Leukemia & Lymphoma|April 15, 2003
FLT3 and its role in the pathogenesis of acute myeloid leukaemiaJohn T Reilly
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|February 14, 2002
Chronic neutrophilic leukaemia: a distinct clinical entity?John T Reilly
European Journal of Haematology. Supplementum|August 31, 2007
Practical approach to treating essential thrombocythaemia: case studiesJohn T Reilly
Hematological Oncology|February 16, 2006
Idiopathic myelofibrosis: pathogenesis to treatmentJohn T Reilly
Seminars in Oncology|October 6, 2005
Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasiaJohn T Reilly
British Journal of Haematology|March 12, 2002
Class III receptor tyrosine kinases: role in leukaemogenesisJohn T Reilly
American Journal of Hematology|December 24, 2009
Prognosis and survivorship in primary myelofibrosisJohn T Reilly
British Journal of Haematology|December 21, 2004
Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?John T Reilly
Blood Reviews|October 15, 2003
Receptor tyrosine kinases in normal and malignant haematopoiesisJohn T Reilly
Acta Haematologica|October 10, 2002
Cytogenetic and molecular genetic aspects of idiopathic myelofibrosisJohn T Reilly
Leukemia & Lymphoma|April 15, 2003
FLT3 and its role in the pathogenesis of acute myeloid leukaemiaJohn T Reilly
Pageof 8